Carboplatin in combination with weekly Paclitaxel as first-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma unfit to EXTREME schedule

The standard first-line treatment in recurrent/metastatic head and neck squamous cell carcinoma combines Cisplatin, 5 Fluorouracil and Cetuximab, but many patients aren’t eligible. We retrospectively evaluated the efficacy and the tolerability of Carboplatin and Paclitaxel in this indication, mostly...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Pêtre, Adeline, Dalban, Cécile, Karabajakian, Andy, Neidhardt, Eve-Marie, Roux, Pierre Eric, Poupart, Marc, Deneuve, Sophie, Zrounba, Philippe, Fayette, Jérome
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2018
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5955142/
https://ncbi.nlm.nih.gov/pubmed/29774120
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25157
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares